The reduced enrichment following H3K36me3 cfChIP of TP53 WT relative to mutated alleles is in accordance with transcriptional silencing of the TP53 WT locus being a cancer driving mechanism acting in parallel with acquirement of loss‐of‐function mutations acting at the post‐transcriptional level. The gene discussed is TP53; the disease is cancer.